Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is developing a platform that will allow consumers to program cells with the same ease as computers. The company's platform is market agnostic, allowing biotechnology applications in various industries, including food and agriculture, industrial chemicals, and medicines.